Disulfiram-loaded CuO nanocarriers for enhanced synergistic chemodynamic chemotherapy.

J Colloid Interface Sci

Department of Cardiothoracic Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan 316000, PR China. Electronic address:

Published: November 2024

Disulfiram (DSF) metabolites exhibit antitumor properties when bound to Cu. This combination also promotes the generation of reactive oxygen species (ROS), ultimately leading to tumor cell death. In this study, CuO served as a carrier for DSF, forming a dual-drug delivery system with Cu and DSF encapsulated in polydopamine (PDA). In the final delivery system, CuO (DSF-CuO@PDA) was hydrolyzed at the tumor site, releasing both Cu and HO. Cu reacts with DSF metabolites to form Bis(diethyldithiocarbamate)-Cu (CuET), which triggers a Fenton-like reaction that generates ROS. Chemotherapy and chemodynamic therapy exhibited significant tumor-suppressive capabilities, with an inhibition rate of 61 %. In addition, the DSF-CuO@PDA complex demonstrated superlative tumor-targeting ability and biocompatibility.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcis.2024.06.147DOI Listing

Publication Analysis

Top Keywords

dsf metabolites
8
delivery system
8
disulfiram-loaded cuo
4
cuo nanocarriers
4
nanocarriers enhanced
4
enhanced synergistic
4
synergistic chemodynamic
4
chemodynamic chemotherapy
4
chemotherapy disulfiram
4
dsf
4

Similar Publications

Disulfiram/Cu targeting FOXO6 modulates sensitivity of hepatocellular carcinoma to lenvatinib via disrupt choline metabolic.

Cell Signal

December 2024

Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325035, China; Liver Cancer Institute, Zhongshan Hospital of Fudan University, Shanghai 200032, China; National Clinical Research Center for Interventional Medicine, Shanghai 200032, China. Electronic address:

Disulfiram/Cu(DSF/Cu) has a known pharmacokinetic and safety profile, exerting a strong antitumor effect. Oral tyrosine kinase inhibitors including lenvatinib are approved as first-line therapy for treating advanced unresectable hepatocellular carcinoma (HCC). These patients still have limited survival due to drug resistance.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates how disulfiram (DSF), used primarily to treat alcoholism, inhibits monocyte-derived macrophage migration in lung tissue, which is crucial for the development of fibrotic lung disease.
  • - DSF treatment in mice with bleomycin-induced lung fibrosis showed significant reduction in macrophage infiltration and profibrotic gene expression, indicating its potential antifibrotic effects.
  • - The research reveals that DSF works by targeting FROUNT, a regulator of chemokine signaling, which ultimately leads to decreased inflammation and fibrosis in the lungs.
View Article and Find Full Text PDF
Article Synopsis
  • Disulfiram (DSF) is an approved drug for alcoholism that has shown potential anticancer effects by forming a toxic copper complex (Cu(DTC)), but its effectiveness is limited by low formation rates and side effects.
  • A new nanotechnology, HfD-HID-Cu, has been developed to improve cancer treatment by co-delivering a DTC prodrug and copper specifically to tumor sites through activation by a protein (FAPα) that is highly expressed in tumors.
  • This approach not only enhances the targeted anticancer effect of Cu(DTC) but also allows for real-time imaging of tumors, minimizing side effects by keeping the treatment inactive in normal tissues.
View Article and Find Full Text PDF

Matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) is a label-free technique, producing images where pixels contain mass spectra. The technique allows the visualization of the spatial distribution of (bio)molecules from metabolites to proteins, on surfaces such as tissues sections or bacteria culture media. One particularly exciting example of MALDI-MSI use rests on its potential to localize ionized compounds produced during microbial interactions and chemical communication, offering a molecular snapshot of metabolomes at a given time.

View Article and Find Full Text PDF

Disulfiram-loaded CuO nanocarriers for enhanced synergistic chemodynamic chemotherapy.

J Colloid Interface Sci

November 2024

Department of Cardiothoracic Surgery, Zhoushan Hospital, Wenzhou Medical University, Zhoushan 316000, PR China. Electronic address:

Disulfiram (DSF) metabolites exhibit antitumor properties when bound to Cu. This combination also promotes the generation of reactive oxygen species (ROS), ultimately leading to tumor cell death. In this study, CuO served as a carrier for DSF, forming a dual-drug delivery system with Cu and DSF encapsulated in polydopamine (PDA).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!